154 related articles for article (PubMed ID: 2473275)
1. Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains.
Ikeda S; Yanagisawa N; Allsop D; Glenner GG
Lab Invest; 1989 Jul; 61(1):133-7. PubMed ID: 2473275
[TBL] [Abstract][Full Text] [Related]
2. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
Ikeda S; Allsop D; Glenner GG
Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
[TBL] [Abstract][Full Text] [Related]
3. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody.
Ikeda S; Allsop D; Glenner GG
Lab Invest; 1989 Jan; 60(1):113-22. PubMed ID: 2642985
[TBL] [Abstract][Full Text] [Related]
4. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain.
Czasch S; Paul S; Baumgärtner W
Neurobiol Aging; 2006 Feb; 27(2):293-305. PubMed ID: 16002188
[TBL] [Abstract][Full Text] [Related]
5. [The pathogenesis of Alzheimer's disease demonstrated by immunocytochemistry with anti-beta-protein antibody].
Ikeda S
Yakubutsu Seishin Kodo; 1992 Jun; 12(3):141-9. PubMed ID: 1414034
[TBL] [Abstract][Full Text] [Related]
6. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
[TBL] [Abstract][Full Text] [Related]
7. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.
Joachim CL; Mori H; Selkoe DJ
Nature; 1989 Sep; 341(6239):226-30. PubMed ID: 2528696
[TBL] [Abstract][Full Text] [Related]
8. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.
Schmidt ML; Robinson KA; Lee VM; Trojanowski JQ
Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mouse brain histopathology resembles early Alzheimer's disease.
Higgins LS; Holtzman DM; Rabin J; Mobley WC; Cordell B
Ann Neurol; 1994 May; 35(5):598-607. PubMed ID: 7513982
[TBL] [Abstract][Full Text] [Related]
10. Alpha 1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain.
Shoji M; Hirai S; Yamaguchi H; Harigaya Y; Ishiguro K; Matsubara E
Am J Pathol; 1991 Jan; 138(1):247-57. PubMed ID: 1702930
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
12. [An Alzheimer's disease case showing recurrent subcortical hemorrhage: an autopsy findings with immunohistochemical studies of cerebral amyloid deposits].
Maruyama K; Ikeda S; Odajima N; Yanagisawa N
Rinsho Shinkeigaku; 1989 Jul; 29(7):936-9. PubMed ID: 2805520
[TBL] [Abstract][Full Text] [Related]
13. Histopathological studies on senile plaques in brains of patients with Down's syndrome.
Fukuoka Y; Fujita T; Ito H
Kobe J Med Sci; 1990 Dec; 36(5-6):153-71. PubMed ID: 1708000
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer type dementia: diffuse type of senile plaques demonstrated by beta protein immunostaining.
Yamaguchi H; Hirai S; Shoji M; Harigaya Y; Okamoto Y; Nakazato Y
Prog Clin Biol Res; 1989; 317():467-74. PubMed ID: 2481323
[TBL] [Abstract][Full Text] [Related]
15. Neurofibrillary tangles in some cases of dementia pugilistica share antigens with amyloid beta-protein of Alzheimer's disease.
Allsop D; Haga S; Bruton C; Ishii T; Roberts GW
Am J Pathol; 1990 Feb; 136(2):255-60. PubMed ID: 2407121
[TBL] [Abstract][Full Text] [Related]
16. Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.
Tagliavini F; Giaccone G; Linoli G; Frangione B; Bugiani O
Prog Clin Biol Res; 1989; 317():1001-5. PubMed ID: 2532368
[TBL] [Abstract][Full Text] [Related]
17. Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome.
Núñez E; Benito C; Tolón RM; Hillard CJ; Griffin WS; Romero J
Neuroscience; 2008 Jan; 151(1):104-10. PubMed ID: 18068305
[TBL] [Abstract][Full Text] [Related]
18. Down's syndrome in middle age. Topographical distribution and immunoreactivity of brain lesions in an autopsied patient.
Yoshimura N; Kubota S; Fukushima Y; Kudo H; Ishigaki H; Yoshida Y
Acta Pathol Jpn; 1990 Oct; 40(10):735-43. PubMed ID: 1963256
[TBL] [Abstract][Full Text] [Related]
19. [Alzheimer's disease and Down's syndrome. Some recent etiopathogenic data].
Golaz J; Charnay Y; Vallet P; Bouras C
Encephale; 1991; 17(1):29-31. PubMed ID: 1669030
[TBL] [Abstract][Full Text] [Related]
20. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease.
Noda-Saita K; Terai K; Iwai A; Tsukamoto M; Shitaka Y; Kawabata S; Okada M; Yamaguchi T
Acta Neuropathol; 2004 Nov; 108(5):435-42. PubMed ID: 15372280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
